Ceribell is a fast growing venture-backed medical device start-up company founded by two faculty members at Stanford University. Our primary mission is to improve neurological care for emergency and ICU patients. Ceribell is focused on making EEG widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizures. The System can be set up by any healthcare provider within minutes. Now with Clarity, Ceribell offers 24/7 continuous bedside EEG monitoring and alert.
neurodiagnostics • Brain waves • Electroencephalography (EEG) • Epilepsy • Seizures
51 - 200 employees
💰 $50M Series C on 2022-09
October 5, 2024
51 - 200
Responsible for growth and education in critical care using Ceribell technology.
🇺🇸 United States – Remote
💵 $100k - $180k / year
💰 $50M Series C on 2022-09
⏰ Full Time
🟡 Mid-level
🟠 Senior
💰 Account Manager